Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00495573 · ClinicalTrials.gov registry record
HSV-2 Shedding Resolution After Acyclovir Treatment
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 36
- Enrollment target
NCT00495573 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 36 participants.
The verdict
NCT00495573 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the pattern of viral shedding after beginning treatment with acyclovir for a clinical recurrence of genital herpes and to compare it with the pattern of viral shedding during an untreated clinical recurrence of genital herpes.
Interventions
- DRUG acyclovir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2007-06 |
| Est. Completion | 2012-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00495573
The ClinicalTrials.gov registry entry for NCT00495573 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which acyclovir is the first listed.
NCT00495573 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00495573 about?
NCT00495573 is a clinical study titled "HSV-2 Shedding Resolution After Acyclovir Treatment". The purpose of the study is to evaluate the pattern of viral shedding after beginning treatment with acyclovir for a clinical recurrence of genital herpes and to compare it with the pattern of viral shedding during an untreated clinical recurrence of genital herpes.
What is the current status of trial NCT00495573?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2007-06. Estimated completion is 2012-03.
What interventions are being tested in trial NCT00495573?
The interventions under investigation include: acyclovir (DRUG).
Who is sponsoring clinical trial NCT00495573?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.